The evidence is clear: breastfeeding is one of the most effective ways to ensure healthy development in children. However, the reality is that breastfeeding, let alone exclusive breastfeeding, isn’t always possible. In fact, over 4 out of 5 moms in the US transition to dairy-based infant formula before the recommended six-month breastfeeding period ends.
Whether it’s low milk production, medical challenges, incompatible workplaces, or the ongoing stigma around breastfeeding in public, mothers often feed infant formula out of necessity rather than preference. Parents and caregivers are left with nutritionally suboptimal, mostly dairy-based options. BIOMILQ is developing a new choice for infant nutrition that lessens the trade-off between babies’ nutrition, mothers’ wellbeing, and the future of our environment.
BIOMILQ is enabling the next generation to thrive by producing cultured breastmilk that offers supplemental nutrition to mother’s milk with the practicality of formula.
Breastmilk contains thousands of unique molecules blended in perfect proportion to nourish an infant through some of the most crucial stages of growth. BIOMILQ is harnessing the natural potential of human mammary epithelial cells to create cultured breastmilk outside of the body.
CEO & Co-Founder
CSO & Co-Founder
- Infant Nutrition: Infant formula is known to be nutritionally inferior to breastmilk but fed widely to babies throughout the world
- Women’s Health & Empowerment: Little development has been made to reduce trade-offs between women’s health and the health of babies
- Climate Change & Animal Agriculture: 5700 metric tons of CO2 are created for one year’s supply of infant formula and 4300 gallons of freshwater are consumed in the dairy production and processing of milk for infant formula